Company news
Bluenergies Ltd. news in 2011
Bluenergies Ltd.'s news releases, calls and decks from 2011, newest first.
BELLUS Health and Integris Pharma Ltd. enter into exclusive license agreement for VIVIMIND(tm) in Greece and Cyprus
December 1, 2011
OVOS Natural Health Inc. launches VIVIMIND(tm) in Canada
November 28, 2011
BELLUS Health reports results for third quarter ended September 30, 2011, and provides update on VIVIMIND(tm) partnerships
November 9, 2011
BELLUS Health reports results for second quarter ended June 30, 2011
August 10, 2011
Crystal Research Associates Issues Research Report on BELLUS Health Inc.
July 13, 2011
BELLUS health reports results for first quarter ended March 31, 2011
June 8, 2011
BELLUS health delivering on key strategic partnerships and KIACTA(tm) phase III development
May 11, 2011
BELLUS health issues shares in final payment for the exercise of its lease termination option
April 7, 2011
BELLUS health and the agahan group enter into broad license for VIVIMIND(tm) in the Middle East
April 4, 2011
BELLUS health completes restructuring initiatives with repatriation of intellectual property to canada
March 31, 2011
BELLUS health reports results for fourth quarter and year ended December 31, 2010
February 23, 2011
BELLUS health announces phase i results of prodrug NRM8499 intended for the treatment of Alzheimer's disease
January 31, 2011
BELLUS health exercises option to terminate lease
January 14, 2011
Advanced orthomolecular research acquires BELLUS health's Canadian subsidiary OVOS natural health
January 4, 2011